Categories: All postsAnalysts

DATA Communications Management CFO James Lorimer talks to Cantech Letter

After nearly doubling in size through a major acquisition, DATA Communications Management (DATA Communications Management Stock Quote, Chart, News, Analysts, Financials TSX:DCM) is entering what CFO James Lorimer called “a breakout year” as integration efforts give way to growth.

Lorimer spoke with Ticker Take host Jon Erlichman at the 2025 Cantech Investment Conference in Toronto, discussing how technology is helping the Brampton-based company redefine marketing and communications for major Canadian organizations.

“We’re a large print and marketing communications company,” Lorimer said. “What sets us apart in the market is that we use technology to deliver very complex solutions to our clients, both in physical printed and digital communications.”

DCM CFO JAMES LORIMER SITS DOWN WITH JON ERLICHMAN AT THE 2025 CANTECH INVESTMENT CONFERENCE

He said one of the best examples of DCM’s technology in action is its work with the financial services sector.

“We work with pretty much all the large Canadian banks,” Lorimer said. “Across different lines of business, wealth management, retail banking, and insurance, they have very different needs and messages they want to communicate to their clients. We help them pull that all together and do it under consistent branding, but also with specific messaging for different business lines.”

Lorimer said the company has faced short-term headwinds, including postal service disruptions that affected some operations, but added that momentum remains positive.

“Business is doing well,” he said. “We’ve had some headwinds in the current markets… Despite that, we’ve got a lot of good things going on in the sales pipeline, and I’d say our sales pipeline is healthier than it’s ever been before.”

Lorimer said 2026 should be a turning point.

“We think 2026 will be a bit of a breakout year for us,” he said. “We made a major acquisition two years ago, almost doubled the size of our business. We spent the next 18 months integrating that, and the integration is well behind us now. We’ve got one team very aligned from a sales, commercial strategy, and go-to-market strategy. It’s been gaining traction this year, and we look to really accelerate that next year.”

In April 2023, DCM acquired the Canadian operations of R.R. Donnelley & Sons (RRD Canada) for $130.8-million, a move that nearly doubled the company’s scale and expanded its client base across the country.

-30-

Tagged with: dcm
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

14 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

14 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

14 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

14 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

14 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

14 hours ago